• News
  • SAN DIEGO
  • BioTech

Isis surges on diabetes tests

Shares of Carlsbad’s Isis Pharmaceuticals (NYSE: ISIS) surged on Tuesday evening and Wednesday after the company announced positive results from phase 2 testing of a proposed treatment for diabetes.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Isis Pharmaceuticals Inc.

Company Website

1896 Rutherford Road
Carlsbad, CA 92008

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ISIS
59.55
  2.07  
+ 3.60%
1,972,915,000
65.13
22.25

Insider Trade Data

Date Insider Shares Type Value
12/01/2014 O Neil, Patrick R 1,500 Sell $76,815
12/01/2014 O Neil, Patrick R 1,500 Exchange $10,875
12/01/2014 O Neil, Patrick R 1,500 Sell $76,815
12/01/2014 O Neil, Patrick R 1,500 Exchange $10,875
11/03/2014 O Neil, Patrick R 1,500 Sell $69,255

Isis Pharmaceuticals Inc. Executive(s):

Stanley Crooke

  • Chief Executive Officer, Founder, President, Chairman

Similar Companies

NAICS - 325414 - Biological Product (except Diagnostic) Manufacturing
SIC - 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Subscribe Today!